Molecular Subtype
Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive
CI-CAN-00004636Explore in graph →
Hematologic14 active trials
Loading cancer entity…
Molecular Subtype
CI-CAN-00004636Explore in graph →
Clinical trials
95 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (24)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07259161 | Modified Conditioning Regimen for CML-BP | not yet recruiting | Phase 2 | 40 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 0 | Dec 2, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Dec 2, 2025source: clinicaltrials